Fred Lublin from Mount Sinai Medical Center: Why Relapses Matter in Multiple Sclerosis Care
JUNE 06, 2016
With a lot of the attention in multiple sclerosis care turning to finding treatments for progressive forms of the disease those who suffer relapses are in some ways being left in the shadows of treatment discoveries and care.
Fred Lublin, MD, from Mount Sinai Medical Center gave one of the prominent talks during the annual meeting of the Consortium of Multiple Sclerosis Centers discussing why it is important to not lose sight of treating relapses today. With 14 medications now approved for relapsing remitting multiple sclerosis Lublin said doctors can help their patients manage their likelihood of relapse but still must keep an eye on their care to ensure their condition does not get worse over time.